Breast cancer is known to be a very heterogeneous tumor entity, and the expression of the different LPAR, and thus, the influence of the ATX-LPA axis, varies depending on the breast cancer subtype or cell line [17,18,19]. This evidence concerns the gene ENPP2 and neoplasm.